¹⁸F-labelled fluorodeoxyglucose-positron emission tomography (FDG-PET) heterogeneity of response is prognostic in dabrafenib treated BRAF mutant metastatic melanoma

Matteo S. Carlino^*, Catherine A B Saunders, Lauren E. Haydu, Alexander M. Menzies, C. Martin Curtis, Peter F. Lebowitz, Richard F. Kefford, Georgina V. Long

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review